CSIMarket Company Name, Ticker, Industry, else..
 
Y mabs Therapeutics inc   (NASDAQ: YMAB)
 

Y Mabs Therapeutics Inc's Suppliers Performance

YMAB's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
YMAB Costs vs Sales of Suppliers Growth Y Mabs Therapeutics Inc's cost of sales deteriorated by -33.64 % year on year, relative to one quarter ago cost of sales fell by -33.33 % in Q2.

• More on YMAB Suppliers



Y Mabs Therapeutics Inc's cost of sales deteriorated by -33.64 % year on year, compare to one quarter ago cost of sales fell by -33.33 % in Q2.

• More on YMAB Suppliers




Y Mabs Therapeutics Inc's Comment on Supply Chain


The drug substances GD2-SADA and CD38-SADA are manufactured by Rentschler Biopharma SE in Laupheim, Germany, using cell culture in a fed-batch bioreactor. The drug product is produced and filled at Patheon/Thermo Fisher in Ferentino, Italy. The DOTA chemical is sourced as a GMP bulk product and filled into a sterile intermediate at Patheon/Thermo Fisher. Radiolabeling of the DOTA intermediate with Lu-177 is conducted at ABX Advanced Biochemical Compounds – Biomedizinische Forschungsreagenzien GmbH in Radeberg, Germany. Patheon/Thermo Fisher serves as the primary contract manufacturer for the drug product, with alternative third-party manufacturers considered as backups.

Y Mabs Therapeutics Inc's Comment on Supply Chain


The drug substances GD2-SADA and CD38-SADA are manufactured by Rentschler Biopharma SE in Laupheim, Germany, using cell culture in a fed-batch bioreactor. The drug product is produced and filled at Patheon/Thermo Fisher in Ferentino, Italy. The DOTA chemical is sourced as a GMP bulk product and filled into a sterile intermediate at Patheon/Thermo Fisher. Radiolabeling of the DOTA intermediate with Lu-177 is conducted at ABX Advanced Biochemical Compounds – Biomedizinische Forschungsreagenzien GmbH in Radeberg, Germany. Patheon/Thermo Fisher serves as the primary contract manufacturer for the drug product, with alternative third-party manufacturers considered as backups.







YMAB's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Y mabs Therapeutics inc 390.19 84.72 -22.22 100
SUBTOTAL 0.00 0.00 0.00 -


Sources: Y mabs Therapeutics inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Y mabs Therapeutics inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.